The role of stem cell transplantation in inflammatory bowel disease

References

• Watts DA, Satsangi J. The genetic jigsaw of inflammatory bowel disease. Gut 2002; 50(Suppl 3)III31–III36
   PubMedGoogle Scholar
• Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993; 14(9)426–430
   PubMedGoogle Scholar
• Yu QT, Saruta M, Avanesyan A, et al. Expression functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis 2007; 13(2)191–199
   PubMedGoogle Scholar
• Uhlig HH, Coombes J, Mottet C, et al. Characterization of FOXP3+CD4+CD25+ and IL-10-secreting CD4+CD25+T cells during cure of colitis. J Immunol 2006; 177(9)5852–5860
   PubMedGoogle Scholar
• Mottet C, Uhlig HH, Powrie F. Cutting edge: Cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003; 170(8)3939–3943
   PubMed Web of Science ®Google Scholar
• Wen Z, Fiocchi C. Inflammatory bowel disease: Autoimmune or immune-mediated pathogenesis?. Clin Dev Immunol 2004; 11(3-4)195–204
   PubMedGoogle Scholar
• Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002; 123(3)689–699
   PubMed Web of Science ®Google Scholar
• Burt RK, Traynor AE. Hematopoietic stem cell transplantation: A new therapy for autoimmune disease. Stem Cells 1999; 17(6)366–372
   PubMedGoogle Scholar
• Drakos PE, Nagler A, Or R. Case of Crohn's disease in bone marrow transplantation. Am J Hematol 1993; 43(2)157–158
   PubMed Web of Science ®Google Scholar
• Kashyap A, Forman SJ. Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease. Br J Haematol 1998; 103(3)651–652
   PubMed Web of Science ®Google Scholar
• Lopez-Cubero SO, Sullivan KM, McDonald GB. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 1998; 114(3)433–440
   PubMed Web of Science ®Google Scholar
• Ditschkowski M, Einsele H, Schwerdtfeger R, et al. Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation 2003; 75(10)1745–1747
   PubMed Web of Science ®Google Scholar
• Scime R, Cavallaro AM, Tringali S, et al. Complete clinical remission after high-dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive and immunomodulator therapy. Inflamm Bowel Dis 2004; 10(6)892–894
   PubMed Web of Science ®Google Scholar
• Kreisel W, Potthoff K, Bertz H, et al. Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant 2003; 32(3)337–340
   PubMed Web of Science ®Google Scholar
• Oyama Y, Craig RM, Traynor AE, et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 2005; 128(3)552–563
   PubMed Web of Science ®Google Scholar
• Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88(6)1818–1825
   PubMed Web of Science ®Google Scholar
• Cooke WT, Mallas E, Prior P, Allan RN. Crohn's disease: Course, treatment and long-term prognosis. Q J Med 1980; 49(195)363–384
   PubMedGoogle Scholar
• Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993; 105(6)1716–1723
   PubMed Web of Science ®Google Scholar
• Masala G, Bagnoli S, Ceroti M, et al. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: The Florence IBD study 1978–2001. Gut 2004; 53(9)1309–1313
   PubMedGoogle Scholar
• Craig RM. Autologous hematopoietic stem cell transplantation for Crohn's disease. Autoimmun Rev 2002; 1(4)244–249
   PubMedGoogle Scholar
• Gratwohl A, Passweg J, Bocelli-Tyndall C, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005; 35(9)869–879
   PubMed Web of Science ®Google Scholar
• Burt RK, Traynor AE, Craig R, Marmont AM. The promise of hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2003; 31(7)521–524
   PubMedGoogle Scholar
• Barkholt L, Lofberg R. Resetting the immune system in refractory Crohn's disease: Is autologous hematopoietic stem cell transplantation the way forward?. Gastroenterology 2005; 128(3)786–789
   PubMedGoogle Scholar
• Burt RK, Marmont A, Oyama Y, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006; 54(12)3750–3760
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Petri M, Smith BD, et al. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med 1998; 129(12)1031–1035
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Snowden JA, Lobo A, et al. Stem cell transplantation for inflammatory bowel disease: Practical and ethical issues. Gut 2000; 46(6)869–872
   PubMedGoogle Scholar
• Brittan M, Hunt T, Jeffery R, et al. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut 2002; 50(6)752–757
   PubMed Web of Science ®Google Scholar
• Brittan M, Chance V, Elia G, et al. A regenerative role for bone marrow following experimental colitis: Contribution to neovasculogenesis and myofibroblasts. Gastroenterology 2005; 128(7)1984–1995
   PubMed Web of Science ®Google Scholar
• Marmont AM. Stem cell transplantation for severe autoimmune diseases: Progress and problems. Haematologica 1998; 83(8)733–743
   PubMedGoogle Scholar
• Snowden JA, Kearney P, Kearney A, et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998; 41(3)453–459
   PubMed Web of Science ®Google Scholar
• Sonwalkar SA, James RM, Ahmad T, et al. Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut 2003; 52(10)1518–1521
   PubMed Web of Science ®Google Scholar
• Spiers AS. Ulcerative colitis after bone-marrow transplantation for acute leukemia. N Engl J Med 1984; 311(19)1259
   PubMed Web of Science ®Google Scholar
• Dickinson AM, Middleton PG, Rocha V, et al. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol 2004; 127(5)479–490
   PubMed Web of Science ®Google Scholar
• Talbot DC, Montes A, Teh WL, et al. Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia. Hosp Med 1998; 59(7)580–581
   PubMedGoogle Scholar
• Soderholm JD, Malm C, Juliusson G, Sjodahl R. Long-term endoscopic remission of crohn disease after autologous stem cell transplantation for acute myeloid leukaemia. Scand J Gastroenterol 2002; 37(5)613–616
   PubMed Web of Science ®Google Scholar
• Anumakonda V, Hayee B, Chung-Faye G. Remission and relapse of Crohn's disease following autologous haematopoietic stem cell transplantation for non-Hodgkin's lymphoma. Gut 2007; 56(9)1325
   PubMed Web of Science ®Google Scholar
• Castro J, Bentch HL, Smith L, et al. Prolonged clinical remission in patients (pts) with inflammatory bowel disease (IBD) after high dose chemotherapy (HDC) and autologous blood stem cell transplantation. Blood Marrow Transplant 1996; 88: 133A
   Google Scholar
• Musso M, Porretto F, Crescimanno A, et al. Successful treatment of resistant thrombotic thrombocytopenic purpura/hemolytic uremic syndrome with autologous peripheral blood stem and progenitor (CD34+) cell transplantation. Bone Marrow Transplant 1999; 24(2)207–209
   PubMedGoogle Scholar